iRhythm Holdings, Inc. (IRTC)
126.42
+3.81
(+3.11%)
USD |
NASDAQ |
Apr 17, 10:41
iRhythm Holdings Research and Development Expense (Quarterly) : 21.05M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Tandem Diabetes Care, Inc. | 46.07M |
| ICU Medical, Inc. | 21.09M |
| Merit Medical Systems, Inc. | 26.54M |
| Abbott Laboratories | 721.00M |
| Plus Therapeutics, Inc. | 2.941M |